Bronchogen
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Bronchogen is a short synthetic peptide bioregulator (Alanine-Aspartate-Glutamate-Leucine) from the Khavinson family, associated with bronchial and respiratory tissue. Such ultra-short peptides are studied for tissue-specific regulatory effects.
| Test | Result | Status |
|---|---|---|
| Purity | 99.2% | Passed ✓ |
Research Information
Bronchogen is studied for peptide-bioregulator effects on gene expression and cellular function in respiratory-tissue models, part of research into how short peptides may modulate tissue-specific protein synthesis and regeneration. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Bronchogen Research & Studies
What is Bronchogen?
Bronchogen is a short synthetic tetrapeptide bioregulator with the amino acid sequence Alanine-Aspartate-Glutamate-Leucine. It belongs to the Khavinson family of ultra-short peptides investigated for tissue-specific regulatory properties. Laboratory research associates this compound with bronchial and respiratory tissue models. It is examined strictly as a research tool for studying peptide-mediated cellular signaling and gene-expression patterns in vitro.
Mechanism of Action
In experimental systems, Bronchogen is studied for its capacity to interact with nuclear components and influence tissue-specific gene expression. Research models explore how this tetrapeptide may modulate transcription of proteins linked to bronchial epithelial function. Investigations focus on complementary peptide-DNA or peptide-chromatin interactions that could alter protein synthesis rates. These mechanisms are characterized exclusively in cell-culture and molecular assays.
Primary Areas of Research
Bronchogen is investigated primarily in respiratory-tissue model systems for effects on cellular protein synthesis and regenerative pathways. Studies examine its influence on gene-expression profiles in bronchial epithelial cell lines and related in-vitro constructs. Additional research areas include modulation of tissue-specific regulatory networks and peptide-driven changes in cellular homeostasis markers. All work remains confined to laboratory and molecular biology settings.
Key Research Findings
Published investigations of short Khavinson-type peptides, including Bronchogen, report alterations in expression of genes associated with epithelial maintenance in cultured respiratory cells. Model systems have documented shifts in protein-synthesis patterns consistent with tissue-specific bioregulatory activity. Findings emphasize complementary binding and selective transcriptional effects rather than broad pharmacological actions. Results are derived solely from controlled in-vitro and biochemical experiments.
Research Handling and Considerations
Bronchogen is supplied exclusively for in-vitro laboratory research and must be handled under standard peptide-research protocols. Researchers typically reconstitute the lyophilized material in appropriate sterile buffers and store aliquots under recommended cold conditions to preserve integrity. Experimental design should incorporate vehicle controls and validated assays for gene-expression or protein-synthesis endpoints. The compound is not intended for any use outside controlled research environments.
Frequently Asked Questions
Bronchogen consists of the tetrapeptide sequence Alanine-Aspartate-Glutamate-Leucine.
Explore Other High-Purity Peptides
Thymalin
Thymosin Alpha-1
Cardiogen
